Candriam SCA’s Avadel Pharmaceuticals AVDL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-85,000	Closed	-$428K	–	811
2020 Q3	$428K	Hold	85,000	–	–	﹤0.01%	721
2020 Q2	$687K	Buy	+85,000	New	+$687K	0.01%	661
2019 Q1	–	Sell	-62,000	Closed	-$160K	–	795
2018 Q4	$160K	Hold	62,000	–	–	﹤0.01%	772
2018 Q3	$272K	Hold	62,000	–	–	﹤0.01%	762
2018 Q2	$380K	Hold	62,000	–	–	0.01%	725
2018 Q1	$452K	Hold	62,000	–	–	0.01%	688
2017 Q4	$508K	Sell	62,000 -49,000	-44%	-$401K	0.01%	674
2017 Q3	$1.17M	Hold	111,000	–	–	0.02%	546
2017 Q2	$1.22M	Hold	111,000	–	–	0.02%	544
2017 Q1	$1.08M	Buy	+111,000	New	+$1.08M	0.02%	552
2016 Q4	–	Sell	-111,000	Closed	-$1.38M	–	672
2016 Q3	$1.38M	Hold	111,000	–	–	0.03%	437
2016 Q2	$1.19M	Hold	111,000	–	–	0.03%	401
2016 Q1	$1.22M	Sell	111,000 -44,600	-29%	-$490K	0.03%	400
2015 Q4	$1.9M	Buy	155,600 +25,000	+19%	+$305K	0.05%	303
2015 Q3	$2.13M	Sell	130,600 -1,400	-1%	-$22.8K	0.05%	330
2015 Q2	$2.8M	Sell	132,000 -76,000	-37%	-$1.61M	0.06%	326
2015 Q1	$3.74M	Buy	208,000 +16,000	+8%	+$288K	0.08%	302
2014 Q4	$3.29M	Buy	+192,000	New	+$3.29M	0.07%	296